Basic Information
| RNALocate ID: | RLID:11002507 |
| RNA Symbol: | hsa-miR-376a-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-376a |
| RNA ID: | miRBase:MIMAT0000729 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23666971 |
| Tissue/Cell Line: | Follicular fluid |
| Method: | Microarray |
| Description: | The TaqMan miRNA Array Card version 3.0, which includes 766 mature miRNAs, detected the presence of miRNAs in both the microvesicles and the supernatant. A total of 120 miRNAs (cycle threshold [Ct] <37) were found in the in microvesicles extracted from 8 mL fresh follicular fluid, and 82 miRNAs (Ct <37) were expressed in 500 uL supernatant (Table 2). Data are collected from Table 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002038 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11002504 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
| RLID:11002505 | Exosome | Brain tissue | 23382797 |
| RLID:11002506 | Exosome | Plasma | 23663360 |
| RLID-D:11000417 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001205 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-376a-3p | Oral squamous cell carcinoma | MNDR-E-MI-45948 |
| MNDR | hsa-miR-376a-3p | Medulloblastoma | MNDR-E-MI-45949 |
| MNDR | hsa-miR-376a-3p | Lymphoma | MNDR-E-MI-45950 |
| MNDR | hsa-miR-376a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-45951 |
| MNDR | hsa-miR-376a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-45952 |
| MNDR | hsa-miR-376a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-45953 |
| MNDR | hsa-miR-376a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-45954 |
| MNDR | hsa-miR-376a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-45955 |
| MNDR | hsa-miR-376a-3p | Breast cancer luminal | MNDR-E-MI-45956 |
| MNDR | hsa-miR-376a-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-45957 |
| MNDR | hsa-miR-376a-3p | Prostate cancer | MNDR-E-MI-45958 |
| MNDR | hsa-miR-376a-3p | Gastric cancer | MNDR-E-MI-45959 |
| MNDR | hsa-miR-376a-3p | Alzheimer disease | MNDR-E-MI-45960 |
| MNDR | hsa-miR-376a-3p | Bladder cancer | MNDR-E-MI-45961 |
| MNDR | hsa-miR-376a-3p | Dysautonomia familial | MNDR-E-MI-45962 |
| MNDR | hsa-miR-376a-3p | Distal muscular dystrophy | MNDR-E-MI-45963 |
| MNDR | hsa-miR-376a-3p | Myotonic dystrophy | MNDR-E-MI-45964 |
| MNDR | hsa-miR-376a-3p | Duchenne muscular dystrophy | MNDR-E-MI-45965 |
| MNDR | hsa-miR-376a-3p | Cardiovascular disease | MNDR-E-MI-45966 |
| MNDR | hsa-miR-376a-3p | Lung cancer | MNDR-E-MI-45967 |
| MNDR | hsa-miR-376a-3p | Down syndrome | MNDR-E-MI-45968 |
| MNDR | hsa-miR-376a-3p | Parkinson disease | MNDR-E-MI-45969 |
| MNDR | hsa-miR-376a-3p | Basal-like breast cancer | MNDR-E-MI-45970 |
| MNDR | hsa-miR-376a-3p | Thyroid cancer | MNDR-E-MI-45971 |
| MNDR | hsa-miR-376a-3p | Pancreatic cancer | MNDR-E-MI-45972 |
| MNDR | hsa-miR-376a-3p | Melanoma | MNDR-E-MI-45973 |
| MNDR | hsa-miR-376a-3p | Giant cell tumor | MNDR-E-MI-45974 |
| MNDR | hsa-miR-376a-3p | Nephroblastoma | MNDR-E-MI-45975 |
| MNDR | hsa-miR-376a-3p | Colon adenocarcinoma | MNDR-E-MI-45976 |
| MNDR | hsa-miR-376a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-45977 |
| MNDR | hsa-miR-376a-3p | Familial ovarian cancer | MNDR-E-MI-45978 |
| MNDR | hsa-miR-376a-3p | Glioblastoma | MNDR-E-MI-45979 |
| MNDR | hsa-miR-376a-3p | Astrocytoma | MNDR-E-MI-45980 |
| MNDR | hsa-miR-376a-3p | Glioma | MNDR-E-MI-45981 |
| MNDR | hsa-miR-376a-3p | Nemaline myopathy | MNDR-E-MI-45982 |
| MNDR | hsa-miR-376a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-45983 |
| MNDR | hsa-miR-376a-3p | Osteosarcoma | MNDR-E-MI-45984 |
| MNDR | hsa-miR-376a-3p | Liposarcoma | MNDR-E-MI-45985 |
| MNDR | hsa-miR-376a-3p | Meningioma | MNDR-E-MI-45986 |
| MNDR | hsa-miR-376a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-45987 |
| MNDR | hsa-miR-376a-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-45988 |
| MNDR | hsa-miR-376a-3p | Adrenocortical cancer | MNDR-E-MI-45989 |
| MNDR | hsa-miR-376a-3p | Bladder urothelial carcinoma | MNDR-E-MI-45990 |
| MNDR | hsa-miR-376a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-45991 |
| MNDR | hsa-miR-376a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-45992 |
| MNDR | hsa-miR-376a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-45993 |
| MNDR | hsa-miR-376a-3p | Cholangiocarcinoma | MNDR-E-MI-45994 |
| MNDR | hsa-miR-376a-3p | Esophageal cancer | MNDR-E-MI-45995 |
| MNDR | hsa-miR-376a-3p | Synovial sarcoma | MNDR-E-MI-45996 |
| MNDR | hsa-miR-376a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-45997 |
| MNDR | hsa-miR-376a-3p | Hepatocellular carcinoma | MNDR-E-MI-45998 |
| MNDR | hsa-miR-376a-3p | Familiar ovarian carcinoma | MNDR-E-MI-45999 |
| MNDR | hsa-miR-376a-3p | B-cell lymphoma | MNDR-E-MI-46000 |
| MNDR | hsa-miR-376a-3p | Barrett's adenocarcinoma | MNDR-E-MI-46001 |
| MNDR | hsa-miR-376a-3p | Hodgkin lymphoma | MNDR-E-MI-46002 |
| MNDR | hsa-miR-376a-3p | Crohn disease | MNDR-E-MI-46003 |
| MNDR | hsa-miR-376a-3p | Colorectal cancer | MNDR-E-MI-46004 |
| MNDR | hsa-miR-376a-3p | Ovarian epithelial cancer | MNDR-E-MI-46005 |
| MNDR | hsa-miR-376a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-46006 |
| MNDR | hsa-miR-376a-3p | Barrett's carcinogenesis | MNDR-E-MI-46007 |
| MNDR | hsa-miR-376a-3p | Breast cancer her3+ negative | MNDR-E-MI-46008 |
| MNDR | hsa-miR-376a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-46009 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1C | Homo sapiens | RR00039082 |
TOP